Precision BioSciences, Inc. (DTIL)
NASDAQ: DTIL · Real-Time Price · USD
6.33
+0.07 (1.12%)
Apr 8, 2026, 1:14 PM EDT - Market open
Precision BioSciences Market Cap
Precision BioSciences has a market cap or net worth of $163.33 million as of April 8, 2026. Its market cap has increased by 279.76% in one year.
Market Cap
163.33M
Enterprise Value
72.69M
1-Year Change
279.76%
Ranking
Category
Stock Price
$6.33
Market Cap Chart
Since March 28, 2019, Precision BioSciences's market cap has decreased from $855.07M to $163.33M, a decrease of -80.90%. That is a compound annual growth rate of -20.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 161.53M | 61.30% |
| Dec 31, 2025 | 100.14M | 242.63% |
| Dec 31, 2024 | 29.23M | -34.32% |
| Dec 29, 2023 | 44.50M | -66.30% |
| Dec 30, 2022 | 132.04M | -70.64% |
| Dec 31, 2021 | 449.68M | 2.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cartesian Therapeutics | 165.42M |
| Whitehawk Therapeutics | 165.19M |
| Tiziana Life Sciences | 163.36M |
| Connect Biopharma Holdings | 161.65M |
| Heron Therapeutics | 152.81M |
| Immunic | 152.64M |
| Molecular Partners AG | 151.17M |
| Spero Therapeutics | 151.10M |